Search Results for "Alzheimers Disease Update"

09:07 EDT 30th August 2016 | BioPortfolio

Matching Channels

Vascular Dementia

Vascular Dementia accounts for 25% of all dementias (the second most commen cause after Alzheimers. It is the cumulative effects of many small strokes - patients often have evidence of vascular path...

Eye disease

Gaucher's disease

Gaucher's (go-SHAYZ) disease occurs when certain harmful fatty substances accumulate to excessive levels in your liver, spleen, lungs, bone marrow and, less commonly, brain. This accumulation of...

Mayaro disease

MarchiafavaBignami Disease

Matching News

Alzheimer’s Disease and Diabetes Mellitus

Alzheimer’s Disease and Diabetes Mellitus Larry H. Bernstein, MD, FCAP, Curator LPBI   Unraveling Alzheimer’s:Making Sense of the Relationship between Diabetes and Alzheimer’s Disease1 ...

ADI Monthly Update - May 2016

Read our monthly update, including highlights from the 32nd International Conference of Alzheimer's Disease International in Budapest, new reports on dementia friendly communities, expansion of ou...

Teva Offers Update on NDA for Huntington Disease Drug

​Teva announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for SD-809 (deutetrabenazine) tablets ...

IntelGenx starts phase 1 clinical trial of montelukast

IntelGenx has started a phase 1 clinical trial of montelukast, a drug repurposing opportunity for the treatment of degenerative diseases of the brain, such as: mild cognitive impairment and Alzheimers...

Legionnaires Disease on Rise in US--2016 Update

Despite recent outbreaks of Legionnaires disease, experts believe that the infection is underdiagnosed. CDC Expert Commentary

UPDATE 1-Amicus' Fabry disease drug gets European Commission approval

May 31 (Reuters) - Amicus Therapeutics Inc said on Tuesday the European Commission approved the use of migalastat, its experimental treatment for Fabry disease, an inherited disease that creates pain ...

CORRECTED-BRIEF-Cynapsus provides European clinical update for Parkinson's drug

* Provides European clinical update for APL-130277 for the treatment of off episodes in patients with Parkinson's disease Source text for Eikon: Further company coverage:

Of Mice And Men: Translation In Psychiatric Disease

We've Moved! Update your Reader Now.This feed has moved to: your reader now with this changed subscription address to get your latest updates from us.

Matching PubMed Articles

Some aspects of the immune system in the pathogenesis of Alzehimers disease.

Alzheimers disease is a severe neurodegenerative disorder and the most common cause of dementia in the population above 60 years of age. Beta-amyloid accumulation and neurofibrillary tangles formation...

Trends in urological stone disease: a 5-year update of Hospital Episode statistics.

To provide a 5-year follow-on update on the changes in prevalence and treatment of upper urinary tract stone disease in the UK.

An update on ocular allergy.

The update reviews prevalence, classification, cause, and treatment options for allergic eye disease.

Care of Women During Menopause.

We would like to introduce a new section in the Journal of Women's Health, the Clinical Update. Important studies are continually published in both this Journal and other medical publications. However...

Update of hidradenitis suppurativa in Primary Care.

Hidradenitis suppurativa is a prevalent disease that is noted for its clinical variability and by its severe impact on quality of life. A meticulous scientific literature review is presented in this a...

Search Whole site using Google

Quick Search
Advertisement Advertisement